US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 143 actively recruiting studies with Louisiana sites out of 143 registered in total. The busiest research areas in Louisiana are B Acute Lymphoblastic Leukemia, Venous Leg Ulcer, Ulcerative Colitis. Leading sponsors running trials in the state include Tulane University, National Cancer Institute (NCI), Pennington Biomedical Research Center. By stage, Louisiana trials break down as Phase 1 (8), Phase 2 (32), Phase 3 (53), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
143
Recruiting Now
143
← Back to US Map
Top Conditions in Louisiana
B Acute Lymphoblastic Leukemia (3)Venous Leg Ulcer (3)Ulcerative Colitis (3)Obesity (3)Malignant Solid Neoplasm (2)Human Immunodeficiency Virus (2)Solid Tumor (2)Prostate Adenocarcinoma (2)Mitral Valve Insufficiency (2)Chronic Low-back Pain (2)Heart Failure (2)Alzheimer Disease (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 143 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 143. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including B Acute Lymphoblastic Leukemia, Venous Leg Ulcer, Ulcerative Colitis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06388967 N/A
Recruiting
Pancreatic Cancer Detection Consortium
Condition
Pancreatic Cancer
Enrollment
2,000 pts
Location
United States, Japan, South Korea
Sponsor
City of Hope Medical Center
View Trial →
NCT05723653 N/A
Recruiting
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Int...
Condition
HIV Seropositivity
Enrollment
900 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT07525375 Phase 2
Recruiting
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled ...
Condition
Asthma
Enrollment
69 pts
Location
United States, Argentina, Czechia
Sponsor
AstraZeneca
View Trial →
NCT06228326 Phase 1, Phase 2
Recruiting
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies A...
Condition
Lung Cancer, Non-small Cell
Enrollment
250 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
View Trial →
NCT05906758 Phase 3
Recruiting
Ultra-Low Contrast Angiography in AKI
Condition
Acute Kidney Injury
Enrollment
32 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT04510597 Phase 3
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Wi...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
364 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05884476 N/A
Recruiting
Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans
Condition
Suicidal Ideation
Enrollment
180 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07061613 N/A
Recruiting
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for ...
Condition
Venous Leg Ulcer
Enrollment
10 pts
Location
United States
Sponsor
NuScience Medical Biologics, L
View Trial →
NCT06875310 Phase 3
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembr...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
630 pts
Location
United States, Argentina, Australia
Sponsor
Mirati Therapeutics Inc.
View Trial →
NCT07691541 N/A
Recruiting
Implementation Models for Blood Pressure Monitoring in Pregnancy and Postpartum:...
Condition
Maternal Health Care
Enrollment
2,000 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT07011732 Phase 3
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the T...
Condition
Alzheimer Disease
Enrollment
426 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07253285 Phase 3
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Ado...
Condition
Overweight
Enrollment
460 pts
Location
United States, Australia, Austria
Sponsor
Novo Nordisk A/S
View Trial →
NCT07517263 Phase 3
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to E...
Condition
Cardiovascular Disease and Lipoprotein(a)
Enrollment
5,700 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT04757116 N/A
Recruiting
Post-Market Study to Assess iTind Safety in Comparison to UroLift
Condition
Benign Prostatic Hyperplasia (BPH)
Enrollment
256 pts
Location
United States, United Kingdom
Sponsor
Olympus Corporation of the Ame
View Trial →
NCT04583514 N/A
Recruiting
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
Condition
Overweight and Obesity
Enrollment
58 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT06848348 Phase 2
Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced ...
Condition
Chemotherapy Induced Neuropathic Pain
Enrollment
240 pts
Location
United States
Sponsor
Dogwood Therapeutics Inc.
View Trial →
NCT06727604 Phase 2
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatme...
Condition
Graves' Disease
Enrollment
240 pts
Location
United States, Belgium, Georgia
Sponsor
Immunovant Sciences GmbH
View Trial →
NCT07190807 N/A
Recruiting
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent...
Condition
Chronic Pain
Enrollment
70 pts
Location
United States
Sponsor
Boston Scientific Corporation
View Trial →
NCT07573462 Phase 3
Recruiting
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy...
Condition
Pneumococcal Disease
Enrollment
2,400 pts
Location
United States, Australia, Canada
Sponsor
Pfizer
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
View Trial →
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
View Trial →
NCT07113522 Phase 2
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Condition
Inflammatory Bowel Disease (IBD)
Enrollment
140 pts
Location
United States, Canada, Georgia
Sponsor
Mirador Therapeutics, Inc.
View Trial →
Page 4 of 6 — 143 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology